When the stock market is experiencing a great deal of volatility, savvy investors seek out under the radar and undervalued companies whose businesses are trending in the right direction. One company that clearly exemplifies this feature is NextPlat Corp. (NASDAQ: NXPL).
NextPlat is no one-trick pony. NextPlat is a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide.
The Company boasts more than 60,000 E-commerce customers via dozens of brand name platforms in more than 190 countries and has over 10,000 individual product listings. On the healthcare side, Nextplat dispenses approximately half a million prescriptions and OTC products each year. Plus, the Company has high-end contract management and enhanced data reporting.
NextPlat just recently announced a joint venture with a HealthWarehouse.com, a healthcare E-commerce company. This joint venture will enable the Nextplat healthcare division to fulfill prescriptions and deliver OTC products to consumers in all 50 U.S. states. The Company currently generates about 75% of its total revenue (estimated to be $55 million for 2025) just in the state of Florida which means that in 2026 and beyond, NextPlat will be dramatically increasing its reach.
This new relationship should not be a surprise to longtime NextPlat investors. The Company has a history of growth through acquisitions, joint ventures, and collaborations. NextPlat also operates an e-Commerce communications division offering voice, data, tracking, and IoT products and services worldwide.
On the E-commerce front, NextPlat is generating revenues 24x7x365 through the sale of communications, IoT hardware and associated high-margin, recurring revenue airtime plans, in addition to the consumer product listings on well-known platforms. Noteworthy platforms and relationships include Amazon (NASDAQ:AMZN) and Walmart (NYSE:WMT) in the US along with Alibaba (NASDAQ: BABA) and JD.com (NASDAQ:JD) in Asia.
On March 31, 2026, Nextplat will be releasing its full year 2025 financial results. Management has already indicated that full year revenue should reach $55 million and that favorable sequential quarterly growth is carrying over into 2026. In addition, it is adding new high margin healthcare revenue from government subcontracts while operating expenses are expected to decline significantly on a sequential quarterly basis as well.
All these moves indicate NextPlat is trending in the right direction. There is a hidden benefit here as well. The stock currently trades at a market cap of less than 1x sales and at or below the cash on its balance sheet. As the Company continues this path, logic would dictate that the valuation/market cap spread will narrow, driving higher value, in conjunction with revenue and business development growth. A handful of publicly traded peer companies reflect these trends.
Nextplat peers in healthcare that offer similar characteristics and business models include GoodRX (NASDAQ: GDRX) and Hims and Hers Health (NYSE: HIMS). Global E-commerce and technology peers include MercadoLibre (NASDAQ: MELI) and BigCommerce (NASDAQ:BIGC).
Opportunistic investors and traders should check out NextPlat (https://www.nextplat.com/) ahead of and following the upcoming financial results release. As the adage goes, the trend can be your friend.
Disclaimer: This blog post is for informational purposes only and does not constitute financial advice or an endorsement of OTLC or its strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Please ensure to fully read and comprehend our disclaimer found at https://wallstreetpr.com/disclaimer/. WallStreetPR.com has been compensated for content distribution services on NXPL by a 3rd party. We own zero shares of NXPL. WallStreetPR.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of WallStreetPR.com is registered as a securities broker-dealer, broker, investment advisor, or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. This article may contain forward-looking statements as defined under Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. These statements, often incorporating terms like “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or similar expressions about future performance or conduct, are based on present expectations, estimates, and projections, and are not historical facts. They carry various risks and uncertainties that may result in significant deviation from the anticipated results or events. Past performance does not guarantee future results. WallStreetPR.com does not commit to updating forward-looking statements based on new information or future events. Readers are encouraged to review all public SEC filings made by the profiled companies at https://www.sec.gov/edgar/searchedgar/companysearch. It is always important to conduct thorough due diligence and exercise caution in trading. WallStreetPR.com is not managed by a licensed broker, a dealer, or a registered investment adviser. The content here is purely informational and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects, foresees, expects, anticipates, estimates, believes, or understands certain actions to possibly occur are not historical facts and may be forward-looking statements. These statements are based on expectations, estimates, and projections that could cause actual results to differ greatly from those anticipated. Investing in micro-cap and growth securities is speculative and entails a high degree of risk, potentially leading to a total or substantial loss of investment. Please note that no content published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation by WallStreetPR.com or any third-party service provider to buy or sell securities or other financial instruments. The content in this article does not address the circumstances of any specific individual or entity and does not constitute professional and/or financial advice. WallStreetPR.com is not a fiduciary by virtue of any person’s use of or access to this content.
Media Contact
Company Name: WallstreetPR
Contact Person: Steve S
Email: Send Email
Phone: 2144353758
Address:1750 North Collins Blvd Suite 101-V
City: Richardson
State: TX
Country: United States
Website: https://wallstreetpr.com/
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: An Under the Radar Company Trending in the Right Direction
